期刊文献+

舒肝健脾化瘀颗粒治疗非酒精性脂肪性肝炎的临床观察 被引量:7

下载PDF
导出
摘要 目的:观察舒肝健脾化瘀颗粒治疗非酒精性脂肪性肝炎的疗效。方法:将符合诊断标准的病例随机分成两组,每组均为35例。对照组:口服脂必妥片,3片/次,1日3次,3个月为1个疗程;治疗组:口服舒肝健脾化瘀颗粒,每次6g,每日3次,疗程3个月。观察两组治疗前后症状、体征、肝功、血脂、血糖、胰岛素抵抗指数、血清瘦素的改变。结果:两组治疗后患者症状、体征、血清学指标及肝脏彩超明显改善,治疗组能够明显降低血脂,改善胰岛素抵抗,降低血清瘦素。结论:使用舒肝健脾化瘀颗粒治疗非酒精性脂肪性肝炎有很好的疗效。
出处 《辽宁中医药大学学报》 CAS 2008年第9期71-73,共3页 Journal of Liaoning University of Traditional Chinese Medicine
  • 相关文献

参考文献3

二级参考文献12

  • 1李毅夫,赵水平.胰岛素抵抗综合征.见赵水平主编,临床血脂学[M].长沙:湖南科技出版社,1997:137~151
  • 2Garg A. Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care, 1996, 19: 387~389.
  • 3Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis, 1999, 19: 221~229.
  • 4Ibrahim KM, Nicola WG, Salama SH. Mechanism of insulin resistance and hyper-insulinemia in fatty liver. Boll Chim Farm, 1996, 135: 528~540.
  • 5Lee JH, Rhee PL, Lee JK, Lee KT, Kim JJ, Koh KC, Paik SW, Rhee JC, Choi KW. Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight. Korean J Intern Med,1998, 13: 12~14.
  • 6Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr, 1997, 24:317~321.
  • 7Mavrelis PG, Ammon HV, Gleysteen JJ, Komorowski RA, Charaf UK. Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology, 1983, 3: 226~231.
  • 8Oehler G, Bleyl H, Matthes KJ. Hyperinsulinemia in hepatic steatosis. Int J Obes, 1982, 6 Suppl 1: 137~ 144.
  • 9Goto T, Onuma T, Takebe K, Kral JG. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord, 1995, 19:841 ~845.
  • 10邵建华,袁振芳,李长红,王淑凤,高妍.游离脂肪酸促进基础状态胰岛细胞生长和分泌胰岛素[J].中华内科杂志,1997,36(12):831-832. 被引量:6

共引文献37

同被引文献175

引证文献7

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部